Article Versions Notes

Gangwar SK, Kumar A, Yap KC-H, Jose S, Parama D, Sethi G, Kumar AP, Kunnumakkara AB. Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects. Pharmaceuticals. 2022; 15(5):624. https://doi.org/10.3390/ph15050624

Gangwar, Shailendra Kumar, Aviral Kumar, Kenneth Chun-Hong Yap, Sandra Jose, Dey Parama, Gautam Sethi, Alan Prem Kumar, and Ajaikumar B. Kunnumakkara. 2022. "Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects" Pharmaceuticals 15, no. 5: 624. https://doi.org/10.3390/ph15050624

Gangwar, S. K., Kumar, A., Yap, K. C.-H., Jose, S., Parama, D., Sethi, G., Kumar, A. P., & Kunnumakkara, A. B. (2022). Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects. Pharmaceuticals, 15(5), 624. https://doi.org/10.3390/ph15050624